Pancreatic Neuroendocrine Tumors
629 articles
Testing a Different Approach to Pancreatic Cancer Treatment
A drug that is epigenetic therapy, which alters how DNA behaves, is being tested in a clinical trial for pancreatic cancer.
Facebook Live: Why Is Pancreatic Cancer Research Important?
Dr. David Tuveson and Dr. Allyson Ocean discuss the importance of pancreatic cancer research in this video of a Facebook Live chat.
Facebook Live: Early Detection of Pancreatic Cancer
Dr. Anirban Maitra and Dr. Allyson Ocean discuss the status of tests to provide early detection of pancreatic cancer in this video of a Facebook Live chat.
Chemotherapy Plus Stem Cell Infusion and Vitamins for BRCA Mutated Pancreatic Cancer
A clinical trial for pancreatic cancer patients with a BRCA mutation uses a combination of chemotherapy, vitamins, and stem cells.
PARP Inhibitor as Maintenance for Pancreatic Cancer Patients with BRCA1, BRCA2, or PALB2 Mutations
A new clinical trial tests a PARP inhibitor as maintenance treatment for pancreatic cancer patients with BRCA1/2 or PALB2 mutations.
A New Immunotherapy Combination for Metastatic Pancreatic Cancer
Researchers are looking at a combination of two types of monoclonal antibodies to treat advanced pancreatic cancer.
Let’s Win! Pancreatic Cancer Foundation Appoints Two New Board Members
David Glauber and Sergeant Elvin Howard, Jr., have been appointed to the Let’s Win Board of Directors, effective July 2020.
Drug Onivyde Gives New Hope to Patients with Advanced Pancreatic Cancer
Onivyde (injectable irinotecan), combined with fluorouracil and leucovorin, has been approved as a second-line treatment for advanced pancreatic cancer.
An Army of Investigators—Pancreatic Cancer Doctors and Researchers
The doctors and researchers at Dana-Farber Cancer Institute and the Koch Institute for Integrative Cancer Research at MIT are working hard to develop new treatments for pancreatic cancer.
Managing Metastatic Pancreatic Cancer with Chemotherapy and Diet
A new clinical trial looks at a special diet that tries to curb a patient’s metabolism to slow cancer growth during chemotherapy.
Targeting the Oxidation Pathway to Treat Advanced Pancreatic Cancer
Researchers are testing a new drug that targets the oxidation pathway in order to make standard chemotherapy more effective for stage IV pancreatic cancer.
Patients Needed for Clinical Trial/Research Study of Treatment Targeting Immune System
A clinical trial seeks pancreatic cancer patients with the MSI (microsatellite instability) genetic signature, to test an immunotherapy drug.
Molecular Sequencing Leads to Customized Treatment
When Florida resident Doron Broman was diagnosed with stage IV pancreatic cancer, his decision to get treated in Boston gave him access a PARP inhibitor for maintenance.
Using a Virus to Infect and Destroy Pancreatic Cancer Cells
A clinical trial tests the combination of standard chemotherapy plus a common cold virus that has been modified to kill cancer cells.
Testing the Safety of a New Chemotherapy and Radiation Combination
A clinical trial tests the effectiveness of adding PEGPH20 to standard chemotherapy and radiation in patients with locally advanced pancreatic cancer.